Home › Funds › PSquared Asset Management AG › GPCR
PSquared Asset Management AG position in GPCR
STRUCTURE THERAPEUTICS INC · Health Care
PSquared Asset Management AG reported holding 37,200 shares of GPCR (STRUCTURE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$2.0M, representing 0.87% of its reported portfolio and ranking #12 among its reported holdings. PSquared Asset Management AG has disclosed GPCR holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PSquared Asset Management AG's GPCR position evolved
PSquared Asset Management AG first disclosed a stake in GPCR in Q1 2026 at 35,000 shares (US$1.7M). The position peaked in Q2 2026 at 37,200 shares, worth US$2.0M. Across 2 filings, PSquared Asset Management AG increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 37,200 shares valued at US$2.0M — an increase of 2,200 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 35.00K | $1.69M | New |
| Q2 2026 | 37.20K | $2.00M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GPCR and 13F data
GPCR (STRUCTURE THERAPEUTICS INC) is a Health Care company. 33 other funds we track also report a position in GPCR — the largest reported positions include Avoro Capital Advisors LLC (US$351.8M), Deep Track Capital, LP (US$254.4M), BVF INC/IL (US$180.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GPCR
- Avoro Capital Advisors LLC 6.56M sh · $351.84M · Q2 2026
- Deep Track Capital, LP 4.74M sh · $254.40M · Q2 2026
- BVF INC/IL 3.37M sh · $180.70M · Q2 2026
- ORBIMED ADVISORS LLC 2.21M sh · $118.58M · Q2 2026
- RTW INVESTMENTS, LP 1.61M sh · $86.27M · Q2 2026
- BAKER BROS. ADVISORS LP 1.43M sh · $76.88M · Q2 2026
- Casdin Capital 1.18M sh · $63.06M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.09M sh · $58.29M · Q2 2026
- Siren, L.L.C. 872.97K sh · $46.85M · Q2 2026
- PACIFIC HEIGHTS ASSET MANAGEMENT LLC 800.00K sh · $42.94M · Q2 2026
- Rock Springs Capital Management LP 640.32K sh · $34.37M · Q2 2026
- Logos Global Management LP 500.00K sh · $26.84M · Q2 2026
More on PSquared Asset Management AG
FAQ
How long has PSquared Asset Management AG held GPCR?
PSquared Asset Management AG has disclosed GPCR holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is PSquared Asset Management AG's current position in GPCR?
As of Q2 2026, PSquared Asset Management AG holds 37.20K shares of GPCR (STRUCTURE THERAPEUTICS INC), valued at $2.00M, representing 0.87% of its reported portfolio and ranking #12.
Has PSquared Asset Management AG been buying or selling GPCR?
In the latest 13F filing (Q2 2026), PSquared Asset Management AG increased its position in GPCR. The position peaked in Q2 2026 at 37.20K shares.
Which other funds hold GPCR?
Other major institutional holders of GPCR include Avoro Capital Advisors LLC, Deep Track Capital, LP, BVF INC/IL, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.